Package 1, line item 57, sterility, 510011.BSV
Ended Awarded
- Contract number
- HHSN26100016
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,781
Award facts
- Opportunity
-
- NIHCA2009015 Solicitation number
- Contract value 100% obligated
- $33,780.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100016?
HHSN26100016 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on April 21, 2011.
How much is contract HHSN26100016 worth?
The government has obligated $33,781 on HHSN26100016.
Is contract HHSN26100016 an order under another contract?
Yes. HHSN26100016 is a delivery order under HHSN261200900022I, an indefinite delivery contract.
Was contract HHSN26100016 competed?
The extent of competition for HHSN26100016 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award